144
Views
20
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Epidermal nevi treated by carbon dioxide laser vaporization: A series of 25 patients

, , , , &
Pages 169-174 | Received 23 Feb 2007, Accepted 08 Mar 2007, Published online: 12 Jul 2009
 

Abstract

Background: Epidermal nevi are benign proliferations of epidermis. Numerous treatment modalities have been tried, but no ideal treatment is yet available. Objective: To report our experience with CO2 laser vaporization in the treatment of verrucous epidermal nevi, and to identify which factors could have influence in long‐term results. Methods: A total of 25 patients were treated with the CO2 laser in the superpulsed mode, focalized at 2 W/cm2. The patients were between 3 and 41 years old (mean: 17 years). A total of 44% of lesions were <20 cm2, 40% measured between 20 and 100 cm2 and 16% were >100 cm2. The follow‐up was 4–79 months (mean: 28 months). In 76% of patients, multiple treatment sessions were required. Results: Good results were achieved in 92% of patients with soft, flattened nevi and in only 33% patients with keratotic nevi. In addition, 87% of the latter had moderate results and 12.5% had poor results. Conclusion: We conclude that the CO2 laser in superpulsed mode is an effective and safe treatment for verrucous epidermal nevi and provides fewer recurrences than other laser therapies. We also believe that the most determining factor for the cosmetic result is thickness of the nevus.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.